2022
DOI: 10.1021/acsmedchemlett.2c00387
|View full text |Cite
|
Sign up to set email alerts
|

Novel Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors

Abstract: Provided herein are novel compounds as peptidylarginine deiminase type 4 (PAD4) inhibitors, pharmaceutical compositions, use of such compounds in treating diseases, and processes for preparing such compounds. Important Compound Classes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 6 publications
0
0
0
Order By: Relevance